Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
about
Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysisEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Weight gain and antipsychotics: a drug safety review.Use of aripiprazole for delirium in the elderly: a short review.Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records.Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol.
P2860
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of switching from olan ...... a randomized controlled trial.
@ast
Effects of switching from olan ...... a randomized controlled trial.
@en
type
label
Effects of switching from olan ...... a randomized controlled trial.
@ast
Effects of switching from olan ...... a randomized controlled trial.
@en
prefLabel
Effects of switching from olan ...... a randomized controlled trial.
@ast
Effects of switching from olan ...... a randomized controlled trial.
@en
P2093
P2860
P1476
Effects of switching from olan ...... a randomized controlled trial.
@en
P2093
Ahsan Y Khan
Henry A Nasrallah
Ira D Glick
J Steven Lamberti
Joseph P McEvoy
Matthew J Byerly
Richard M Steinbook
Robert M Hamer
T Scott Stroup
P2860
P304
P356
10.1016/J.SCHRES.2013.01.013
P407
P577
2013-02-21T00:00:00Z